BREAKING
AutoZone (AZO) Q2 2026 earnings decline despite 8% sales growth 3 hours ago Earnings Summary: Zymeworks (ZYME) Q4 FY25 net loss widens 1 day ago Earnings Summary: A snapshot of Smith+Nephew’s (SNN) Q4 2025 report 1 day ago Earnings Summary: Norwegian Cruise Line (NCLH) Q4 FY25 revenue rises 6% 1 day ago Earnings Summary: Highlights of Calumet’s (CLMT) Q4 2025 earnings report 4 days ago Zoom Communications Q4 2025 Earnings Results 5 days ago Agilent Q1 Revenue Rises 7%, Net Income Declines 5 days ago Synopsys Q1 2026 Earnings Results 5 days ago Key highlights from J.M. Smucker’s (SJM) Q3 2026 earnings results 5 days ago Hormel Foods (HRL) Q1 2026 Earnings: Key financials and quarterly highlights 5 days ago AutoZone (AZO) Q2 2026 earnings decline despite 8% sales growth 3 hours ago Earnings Summary: Zymeworks (ZYME) Q4 FY25 net loss widens 1 day ago Earnings Summary: A snapshot of Smith+Nephew’s (SNN) Q4 2025 report 1 day ago Earnings Summary: Norwegian Cruise Line (NCLH) Q4 FY25 revenue rises 6% 1 day ago Earnings Summary: Highlights of Calumet’s (CLMT) Q4 2025 earnings report 4 days ago Zoom Communications Q4 2025 Earnings Results 5 days ago Agilent Q1 Revenue Rises 7%, Net Income Declines 5 days ago Synopsys Q1 2026 Earnings Results 5 days ago Key highlights from J.M. Smucker’s (SJM) Q3 2026 earnings results 5 days ago Hormel Foods (HRL) Q1 2026 Earnings: Key financials and quarterly highlights 5 days ago
ADVERTISEMENT
AlphaGraphs

Bristol Myers Squibb (BMY) Q2 2022 Earnings: Key financials and quarterly highlights

Bristol Myers Squibb (NYSE: BMY) reported second quarter 2022 earnings results today. Total revenue grew 2% year-over-year to $11.9 billion. Net earnings attributable to BMY shareholders stood at $1.4 billion, or $0.66 per share vs. $1.1 billion, or $0.47 per share for the same period a year ago.

$BMY July 28, 2022 1 min read
NYSE
$BMY · Earnings

Bristol Myers Squibb (NYSE: BMY) reported second quarter 2022 earnings results today. Total revenue grew 2% year-over-year to $11.9 billion. Net earnings attributable to BMY shareholders stood at $1.4 billion, or $0.66 per share vs. $1.1 billion, or $0.47 per share for the same period a year ago.

· July 28, 2022

Bristol Myers Squibb (NYSE: BMY) reported second quarter 2022 earnings results today.

Total revenue grew 2% year-over-year to $11.9 billion.

Net earnings attributable to BMY shareholders stood at $1.4 billion, or $0.66 per share vs. $1.1 billion, or $0.47 per share for the same period a year ago.

ADVERTISEMENT